(DOWNLOAD) "All for One, Or One for All?(Case Study)" by The Hastings Center Report " Book PDF Kindle ePub Free
eBook details
- Title: All for One, Or One for All?(Case Study)
- Author : The Hastings Center Report
- Release Date : January 01, 2007
- Genre: Life Sciences,Books,Science & Nature,
- Pages : * pages
- Size : 147 KB
Description
The May 1, 2007, Wall Street Journal reported the case of Penelope London, a four-year-old suffering from a rare cancer. Penelope was diagnosed when she was just sixteen months old as having an aggressive form of neuroblastoma. Doctors gave her only a 25 percent chance of being cured. Three years later, she has undergone not just multiple bouts of the standard cancer treatments--chemotherapy, radiation, bone-marrow transplants, and surgery--but also experimental therapies that have been in progressively earlier stages of human testing. These therapies have yielded varying results for her, but have managed to keep her alive. In November 2006, Penelope's cancer had recurred and no treatment was working. That was when her father heard of Neotropix Inc., a company in Malvern, Pennsylvania, that is developing an experimental cancer drug. The drug contains a live virus that normally strikes pigs. Experiments show that, when introduced into the human body, it may attack certain kinds of cancer cells. However, the drug is still in the earliest phase of safety testing and has only been given to six humans. The first patient died--from the cancer, not the drug--but the Federal Drug Administration put the trial on hold to definitively determine this. Neotropix expects the resumed first-stage testing to last another eighteen months.